Interleukin-2 Pseudomonas exotoxin chimeric protein is cytotoxic to B cell cultures derived from myasthenia gravis patients

Journal of the Neurological Sciences
I SteinbergerHaya Lorberboum-Galski

Abstract

IL-2-PE664Glu is a chimeric cytotoxin consisting of interleukin-2 (IL-2) fused to a mutant form of Pseudomonas exotoxin (PE664Glu). The chimeric cytotoxin has been previously shown to be extremely toxic to both phytohaemagglutinin blasts and mixed leukocyte reaction blasts prepared from monkey and human lymphocytes. To explore the possible clinical utility of IL-2-PE664Glu for autoimmune diseases, particularly in which B cells are involved, we tested the sensitivity of B cell lines derived from myasthenia gravis patients to this chimeric cytotoxin. 65% (15 out of 23) of the tested B cell lines were sensitive to IL-2-PE664Glu mediated cytotoxicity. B cell lines from control donors as well as from patients with another autoimmune disease, multiple sclerosis, were much less sensitive to IL-2-PE664Glu cytotoxicity. Moreover, a control protein lacking the IL-2 as the targeting moiety of the chimera, had no effect toward all B cell lines tested, thus establishing its specific activity. A detailed study of the IL-2 receptor of the patients' B cells, using the PCR technique and FACS analysis, showed that the cells express mainly the beta and gamma chains and at a lower level also the alpha-chain of the IL-2 receptor. Our results sugges...Continue Reading

References

Jan 1, 1978·Scandinavian Journal of Immunology·A K Lefvert, K Bergström
Jul 17, 1992·Science·T TakeshitaK Sugamura
Feb 1, 1992·Clinical Immunology and Immunopathology·S Cohen-KaminskyS Berrih-Aknin
Sep 1, 1991·Transplantation·C P HerbortI Pastan
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J P CaseI Pastan
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H Lorberboum-GalskiI Pastan
Feb 1, 1989·Research in Immunology·H LinkT Olsson
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S Nakajima-IijimaT Kakunaga
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·H Lorberboum-GalskiI Pastan
Jan 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·G Miller, M Lipman
Jan 1, 1984·The Journal of Experimental Medicine·P AmanG Klein
Sep 1, 1984·Microbiological Reviews·J L Middlebrook, R B Dorland
Jan 1, 1981·Annals of the New York Academy of Sciences·D B DrachmanE F Stanley
May 1, 1993·Trends in Pharmacological Sciences·T A Waldmann
Apr 9, 1993·Cell·T Taniguchi, Y Minami
Apr 1, 1993·Clinical Neuropharmacology·A Shah, R P Lisak
May 25, 2013·Journal of Clinical Neuromuscular Disease·G Z Huang, Y L Lo

❮ Previous
Next ❯

Citations

Feb 1, 1997·International Journal of Immunopharmacology·M Wu
Jul 21, 1998·Annals of the New York Academy of Sciences·S Ragheb, R P Lisak
Sep 30, 2005·International Journal of Experimental Pathology·Michael J SegelRaphael Breuer

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.